CHONDROGRID REDUCES PAIN AND SUPPORTS FUNCTIONAL RECOVERY IN LATERAL EPICONDYLITIS

Hydrolyzed collagen is effective in pain reduction and functional recovery of epicondylitis

In this case series, the efficacy and safety of CHondroGrid application in 14 patients with lateral epicondylitis (mean age: 56.4 ± 10 years, mean BMI: 23.2 ± 2.9, 71% female gender) is presented. The outcomes measured were the VAS score at rest, overnight, and on movement. In addition, the functional score “Patient-rated tennis elbow evaluation questionnaire” (PRTEE) and patient satisfaction using the “Short assessment of patient satisfaction” (SAPS) questionnaire were also collected. The endpoints were at one month (T1) and three months (T2) after the last injection. The mean initial resting VAS score was 5.3. The latter improved by 50% as early as 10 days after the first injection. At T1 and T2 it improved by 57% and 94% respectively. The initial mean VAS score at night was 4.5. The latter improved by 47% as early as ten days after the first injection. At T1 and T2 it improved by 43% and 98% respectively.

PRODUCTS USED: CHONDROGRID CHG-004